Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells

BACKGROUND Human prostate cancer LNCaP and PC‐3 cell lines have been extensively used to study prostate cancer progression and to develop therapeutic agents. Although LNCaP and PC‐3 cells are generally assumed to represent early and late stages of prostate cancer, respectively, there is limited info...

Full description

Saved in:
Bibliographic Details
Published inThe Prostate Vol. 69; no. 10; pp. 1077 - 1090
Main Authors Dozmorov, Mikhail G., Hurst, Robert E., Culkin, Daniel J., Kropp, Bradley P., Frank, Mark Barton, Osban, Jeanette, Penning, Trevor M., Lin, Hsueh-Kung
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.07.2009
Wiley-Liss
Subjects
Online AccessGet full text
ISSN0270-4137
1097-0045
1097-0045
DOI10.1002/pros.20960

Cover

More Information
Summary:BACKGROUND Human prostate cancer LNCaP and PC‐3 cell lines have been extensively used to study prostate cancer progression and to develop therapeutic agents. Although LNCaP and PC‐3 cells are generally assumed to represent early and late stages of prostate cancer, respectively, there is limited information regarding gene expression patterns between these two cell lines and its relationship to prostate cancer. METHODS Comprehensive gene expression analysis was performed. Total RNA was isolated from cultured cells and hybridized to Illumina human BeadChips representing 24,526 transcripts. Bioinformatics analysis was applied to identify cell line specific genes as well as biological mechanisms, pathways, and functions related to the genes. RESULTS A total of 2,198 genes were differentially expressed between LNCaP and PC‐3 cells. Using a robust statistical analysis and high significance criteria, 115 and 188 genes were identified to be unique to LNCaP and PC‐3 cells, respectively. LNCaP cells maintained various metabolic pathways including a gene cluster that encodes UDP‐glucuronosyltransferases. Several transcription factors including Talα/β, GATA‐1, and c‐Myc/Max may be responsible for regulating LNCaP cell specific genes. By contrast, PC‐3 cells were characterized by their unique expression of cytoskeleton‐related genes and other genes including VEGFC, IL8, and TGFβ2. CONCLUSIONS This study showed that LNCaP and PC‐3 cells represent two distinct prostate cancer cell lineages. LNCaP cells retain many prostate cell specific properties, whereas PC‐3 cells have acquired a more aggressive phenotype. Future studies for prostate cancer research need to consider similarities and differences between these two cells and their relationship to prostate cancer. Prostate 69:1077–1090, 2009. © 2009 Wiley‐Liss, Inc.
Bibliography:ArticleID:PROS20960
US Department of Veterans Affairs Merit Award
NIH - No. R01 DK069808; No. R01-CA90744; No. P30-ES013580
istex:78064F2C4939C82E8D277C0EDB6E99CFF4D23A7D
ark:/67375/WNG-H6SX5FNC-4
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0270-4137
1097-0045
1097-0045
DOI:10.1002/pros.20960